GeoVax Labs (GOVX) News Today → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free GOVX Stock Alerts $1.47 -0.07 (-4.53%) (As of 02:45 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGeoVax Labs (NASDAQ:GOVX) Stock Price Down 4.8%americanbankingnews.com - April 17 at 2:26 AMGeoVax, Inc.: GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccinefinanznachrichten.de - April 5 at 5:11 AMGeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congressglobenewswire.com - March 28 at 9:00 AMGeoVax Labs Inc (GOVX)investing.com - March 22 at 12:15 PMGeoVax to Present at the 36th Annual Roth Conferenceglobenewswire.com - March 12 at 9:00 AMGeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing Systemglobenewswire.com - March 6 at 9:00 AMGeoVax Labs, Inc. (NASDAQ:GOVX) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 2 at 10:24 AMGeoVax, Inc.: GeoVax Reports 2023 Year-End Financial Results and Provides Business Updatefinanznachrichten.de - March 1 at 8:57 AMGeoVax Reports 2023 Year-End Financial Results and Provides Business Updateglobenewswire.com - February 29 at 4:00 PMEarnings Outlook For Geovax Labsbenzinga.com - February 28 at 3:12 PMGeoVax Labs (GOVX) Price Target Increased by 1170.83% to 77.78msn.com - February 24 at 1:43 AMInMed Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buyingmsn.com - February 23 at 9:35 AMGeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024finance.yahoo.com - February 22 at 10:45 AMGeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024globenewswire.com - February 22 at 9:00 AMGeoVax Labs, Inc. (GOVX)finance.yahoo.com - February 20 at 1:52 PMGeoVax to Present at the 2024 BIO CEO & Investor Conferenceuk.finance.yahoo.com - February 20 at 12:54 AMGeoVax to Present at the 2024 BIO CEO & Investor Conferencefinance.yahoo.com - February 19 at 9:52 AMGeoVax to Present at the 2024 BIO CEO & Investor Conferenceglobenewswire.com - February 19 at 9:00 AMmarketbeat.com - February 1 at 9:33 AMGeoVax Labs (NASDAQ:GOVX) Trading Down 13.1%marketbeat.com - February 1 at 2:15 AMmarketbeat.com - January 31 at 6:08 AMGeoVax Labs to effect 1-for-15 reverse stock split to regain compliance with Nasdaq rulemsn.com - January 29 at 12:50 PMGeoVax, Inc.: GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncologyfinanznachrichten.de - January 8 at 2:41 PMGeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncologyfinance.yahoo.com - January 8 at 9:41 AMGeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine Congressfinance.yahoo.com - November 30 at 4:40 PMGeoVax to Participate in Upcoming December Investor Eventsfinance.yahoo.com - November 29 at 9:41 AMGeoVax COVID-19 Vaccine Clinical Data Presented at World Vaccine Congressfinance.yahoo.com - November 28 at 9:14 AMGeovax Labs (GOVX) Price Target Increased by 12.50% to 6.12msn.com - November 27 at 9:16 AMGeoVax Labs, Inc. (NASDAQ:GOVX) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 10 at 2:58 PMGeoVax, Inc.: GeoVax Reports Third Quarter 2023 Financial Results and Provides Business Updatefinanznachrichten.de - November 9 at 8:47 AMGeovax Labs Earnings Previewbenzinga.com - November 7 at 2:15 PMGeoVax to Report Third Quarter 2023 Financial Results and Provide Corporate Update on November 8, 2023finance.yahoo.com - October 31 at 1:48 PMGeoVax Update: Clinical and Operational Progress Toward Transformative Opportunitiesfinance.yahoo.com - October 24 at 9:47 AMGeoVax, Inc.: GeoVax Receives Notice of Allowance for HIV Vaccine Patentfinanznachrichten.de - October 5 at 1:45 PMGeoVax to Participate in Upcoming October Investor and Industry Eventsfinance.yahoo.com - September 27 at 9:24 AMGeoVax Labs Secures License Agreement With ProBioGenmarkets.businessinsider.com - September 26 at 6:44 PMGeoVax Next-Generation COVID-19 Vaccine Demonstrates Potent Antibody and Cellular Immunity in Immunocompromised Patientsfinance.yahoo.com - September 19 at 9:35 AMGeoVax Presents Corporate Update at the H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - September 12 at 9:58 AMGeoVax Completes Enrollment of Phase 2 Trial for Next-Generation COVID-19 Vaccine Boosterfinance.yahoo.com - September 11 at 1:56 PMGeovax Labs (GOVX) Price Target Increased by 11.11% to 6.12msn.com - August 31 at 5:52 PMGeoVax to Present at the H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - August 31 at 5:52 PMGeoVax, Inc.: GeoVax Receives Notice of Allowance for Malaria Vaccine Patentfinanznachrichten.de - August 28 at 12:43 PMGeoVax Labs, Inc. (NASDAQ:GOVX) Q2 2023 Earnings Call Transcriptfinance.yahoo.com - August 11 at 4:54 PMGeoVax to Report Second Quarter 2023 Financial Results and Provide Corporate Update on Wednesday, August 9, 2023finance.yahoo.com - July 26 at 11:20 PMGeoVax Labs (GOVX) Gets a Buy from Noble Financialmarkets.businessinsider.com - July 24 at 10:52 AMGeoVax Announces Issuance of Ebola Vaccine Patentfinance.yahoo.com - July 24 at 10:52 AMGeoVax, Inc.: GeoVax Announces Initiation of Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemiafinanznachrichten.de - July 20 at 1:14 PMGeoVax Announces Initiation of Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemiafinance.yahoo.com - July 20 at 1:14 PMGeoVax Announces Gedeptin® Presentation at the AACR-AHNS Head and Neck Cancer Conferencefinance.yahoo.com - June 28 at 9:38 AMGeoVax Universal Coronavirus Vaccine Design & Development Approach Published in Vaccine Insightsfinance.yahoo.com - June 27 at 12:46 PM Get GeoVax Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for GOVX and its competitors with MarketBeat's FREE daily newsletter. Email Address World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea. Click here to find out what to do. GOVX Media Mentions By Week GOVX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GOVX News Sentiment▼1.140.42▲Average Medical News Sentiment GOVX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GOVX Articles This Week▼01▲GOVX Articles Average Week Get GeoVax Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for GOVX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ARDS News Today NEXI News Today MBIO News Today BCEL News Today SXTP News Today PHIO News Today EVOK News Today ARAV News Today RNAZ News Today CING News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GOVX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeoVax Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
